Follow
Martin Fellermeyer
Martin Fellermeyer
Postdoctoral scientist, University of Oxford
Verified email at rdm.ox.ac.uk
Title
Cited by
Cited by
Year
The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
S Jostes, D Nettersheim, M Fellermeyer, S Schneider, F Hafezi, ...
Journal of cellular and molecular medicine 21 (7), 1300-1314, 2017
942017
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate
D Nettersheim, A Heimsoeth, S Jostes, S Schneider, M Fellermeyer, ...
Oncotarget 7 (30), 47095, 2016
542016
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate
SV Jostes, M Fellermeyer, L Arévalo, GE Merges, G Kristiansen, ...
International journal of cancer 146 (6), 1592-1605, 2020
372020
The current state and future of T-cell exhaustion research
E Jenkins, T Whitehead, M Fellermeyer, SJ Davis, S Sharma
Oxford Open Immunology 4 (1), iqad006, 2023
192023
LARP1 isoform expression in human cancer cell lines
H Schwenzer, M Abdel Mouti, P Neubert, J Morris, J Stockton, S Bonham, ...
RNA biology 18 (2), 237-247, 2021
162021
A structure-function analysis shows SARS-CoV-2 BA. 2.86 balances antibody escape and ACE2 affinity
C Liu, D Zhou, A Dijokaite-Guraliuc, P Supasa, HME Duyvesteyn, ...
Cell Reports Medicine 5 (5), 2024
62024
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
AH Lippert, C Paluch, M Gaglioni, MT Vuong, J McColl, E Jenkins, ...
Immunity 57 (2), 256-270. e10, 2024
52024
The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes
RAS Barreiro, GDA Guardia, FM Meliso, X Lei, WQ Li, A Savio, ...
RNA biology 20 (1), 311-322, 2023
32023
Combination CD200R/PD-1 blockade in a humanised mouse model
M Fellermeyer, C Anzilotti, C Paluch, RJ Cornall, SJ Davis, U Gileadi
Immunotherapy Advances 3 (1), ltad006, 2023
32023
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
T Gupta, A Antanaviciute, CHJ Lee, RO Babu, A Aulicino, Z Christoforidou, ...
Cancer Cell 42 (5), 797-814. e15, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–10